18618 Federal Register / Vol. 60, No. 70 / Wednesday, April 12, 1995 / Notices

Dated: April 4, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–8919 Filed 4–11–95; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.43(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on December 16, 1994,

Knoll Pharmaceuticals, 30 North

Jefferson Road, Whippany, New Jersey

07981, made application to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the Schedule II controlled substance

Hydromorphone (9150).

The firm plans to produce

Hydromorphone bulk product and

finished dosage units of Dilaudid for

distribution to its customers.

Any other such application and any

person who is presently registered with

DEA to manufacture such substances

may file comments to objections to the

issuance of the above application and

may also file a written request for a

hearing thereon in accordance with 21

CFR 1301.54 and in the form prescribed

by 21 CFR 1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, DC 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than May 12,

1995.

Dated: April 4, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–8918 Filed 4–11–95; 8:45 am]

BILLING CODE @4410–09–M

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.43(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on January 30, 1995,

Mallinckrodt Chemical, Inc.,

Mallinckrodt & Second Streets, St.

Louis, Missouri 63147, made

application to the Drug Enforcement

Administration (DEA) for registration as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ....... I

Methylphenidate (1724) ................. II

Cocaine (9041) .............................. II

Codeine (9050) .............................. II

Diprenorphine (9058) ..................... II

Etorphine Hydrochloride (9059) ..... II

Dihydrocodeine (9120) ................... II

Hydrocodone (9193) ...................... II

Levorphanol (9220) ........................ II

Meperidine (9230) .......................... II

Methadone (9250) .......................... II

Methadone-intermediate (9254) ..... II

Dextropropoxyphene, bulk (nondosage forms) (9273).II

Morphine (9300) ............................. II

Thebaine (9333) ............................. II

Opium extracts (9610) ................... II

Opium fluid extract (9620) ............. II

Opium tincture (9630) .................... II

Opium powdered (9639) ................ II

Opium granulated (9640) ............... II

Oxymorphone (9652) ..................... II

Alfentanil (9737) ............................. II

Sufentanil (9740) ............................ II

Fentanyl (9801) .............................. II

The firm plans to produce bulk

finished products for distribution to its

customers.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the above application and

may also file a written request for a

hearing thereon in accordance with 21

CFR 1301.54 and in the form prescribed

by 21 CFR 1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistant Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed on later than May 12,

1995.

Dated: April 4, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–8920 Filed 4–11–95; 8:45 am]

BILLING CODE 4410–09–M

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated January 24, 1995, and

published in the Federal Register on

February 6, 1995, (60 FR 7071),

Orpharm, Inc., 728 West 19th Street,

Houston, Texas 77008, made

application to the Drug Enforcement

Administration to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Methadone (9250) .......................... II

Methadone intermediate (9254) ..... II

Levo-alphacetylmethadol (1948) .... II

A comment was filed by a registered

manufacturer in which it was stated that

a hearing would not be requested if the

DEA can determine that Orpharm will

manufacture methadone and

methadone-intermediate solely for the

production of LAAM. The DEA has

determined that this is the case.

Therefore, pursuant to Section 303 of

the Comprehensive Drug Abuse

Prevention and Control Act of 1970 and

Title 21, Code of Federal Regulations,

§ 1301.54(e), the Deputy Assistant

Administrator, Office of Diversion

Control, hereby orders that the

application submitted by the above firm

for registration as a bulk manufacturer

of the basic classes of controlled

substances listed above is granted.

Dated: April 4, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–8921 Filed 4–11–95; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Bureau of Labor Statistics

Business Research Advisory Council;

Notice of Meeting and Agenda

The regular Spring meeting of the

Committee on Occupational Safety and

Health Statistics of the Business

Research Advisory Council will be held

on May 4, 1995, at 1:00 p.m. The

meeting will be held in Meeting Room

9 of the Postal Square Building

Conference Center, 2 Massachusetts

Avenue, NE., Washington, DC.

The Business Research Advisory

Council and its committees advise the

Bureau of Labor Statistics with respect

to technical matters associated with the

Bureau’s programs. Membership

consists of technical officers from

American business and industry.

The schedule and agenda for the

meeting is as follows:

Thursday, May 4, 1995

1:00–4:00 p.m.—Committee on

Occupational Safety and Health

Statistics

1. Report on the demographics of

injured/ill workers and the

circumstances of their injuries and

illnesses as reported in the 1993